These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 23615394)
1. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90. Lau WY; Sangro B; Chen PJ; Cheng SQ; Chow P; Lee RC; Leung T; Han KH; Poon RT Oncology; 2013; 84(5):311-8. PubMed ID: 23615394 [TBL] [Abstract][Full Text] [Related]
2. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis]. Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343 [No Abstract] [Full Text] [Related]
6. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality. Kim DY; Han KH Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821 [TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054 [TBL] [Abstract][Full Text] [Related]
11. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. Fidelman N; Kerlan RK AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Peng BG; He Q; Li JP; Zhou F Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298 [TBL] [Abstract][Full Text] [Related]
13. [Hepatic resection with removal of tumor thrombi for hepatocellular carcinoma with tumor thrombi in portal vein and curative analysis]. Fan J; Wu Z; Tang Z; Yu Y; Zhou J; Qiu S; Zhang B Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):8-11. PubMed ID: 11829766 [TBL] [Abstract][Full Text] [Related]
14. A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis. Jia Z; Jiang G; Tian F; Zhu C; Qin X Saudi J Gastroenterol; 2016; 22(5):353-359. PubMed ID: 27748320 [TBL] [Abstract][Full Text] [Related]
15. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010 [TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study. Luo J; Guo RP; Lai EC; Zhang YJ; Lau WY; Chen MS; Shi M Ann Surg Oncol; 2011 Feb; 18(2):413-20. PubMed ID: 20839057 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma]. Wu DH; Chen LH Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus:a multicenter study. Xiang X; Lau WY; Wu ZY; Zhao C; Ma YL; Xiang BD; Zhu JY; Zhong JH; Li LQ Eur J Surg Oncol; 2019 Aug; 45(8):1460-1467. PubMed ID: 31005471 [TBL] [Abstract][Full Text] [Related]
19. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279 [TBL] [Abstract][Full Text] [Related]
20. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]